AGP Executive Report
Last update: 2 hours agoHungary biotech: Gedeon Richter and Hetero Labs signed a global collaboration to jointly develop, register and commercialize semaglutide generics, with EU and US submissions planned for 2027. Cancer diagnostics: Urteste enrolled the first patient in its Panuri urine-based pancreatic cancer study, aiming for interim results in Q4 2026. EV industry in Hungary: BYD says it will prioritize Hungary after pausing a planned Turkey plant, while also pushing its ambition to become the world’s biggest automaker within five years. Energy tech: Rondo Energy’s modular thermal storage “heat battery” targets industrial heat and steam use by charging with renewable power and storing heat for days. EU policy & security mood: A new ECFR survey finds only 11% of Europeans see the US as an ally, boosting support for stronger European defense spending. Local business pressure: Coface reports late payments are widespread among Hungarian SMEs, raising insolvency risks. Media freedom: An EFJ workshop in Brussels focused on how EU rules like the Media Freedom Act and AI Act should work in practice for journalists. Industry ties: Bahrain–Hungary’s industrial partnership forum highlighted engineering, AI, renewables and logistics cooperation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.